Location · Shreveport, LA
Clinical trials in Shreveport, LA
49 recruiting studies have a site in Shreveport, and 7 of them accept healthy volunteers.
49 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Eli Lilly and Company
- Location
- Shreveport, LA + 136 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Eli Lilly and Company
- Location
- Shreveport, LA + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Eli Lilly and Company
- Location
- Shreveport, LA + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Eli Lilly and Company
- Location
- Shreveport, LA + 34 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent…
Bausch Health Americas, Inc.
- Location
- Shreveport, LA + 22 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 2
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Hoffmann-La Roche
- Location
- Shreveport, LA + 8 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
GlaxoSmithKline
- Location
- Shreveport, LA + 50 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
AstraZeneca
- Location
- Shreveport, LA + 120 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Hoffmann-La Roche
- Location
- Shreveport, LA + 58 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
Intra-Cellular Therapies, Inc.
- Location
- Shreveport, LA + 26 other US sites
- Eligibility basics
- Ages 5–17
- Recruiting
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
ReGelTec, Inc.
- Location
- Shreveport, LA + 13 other US sites
- Eligibility basics
- Ages 22–85
- RecruitingPhase 2/Phase 3
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Vertex Pharmaceuticals Incorporated
- Location
- Shreveport, LA + 26 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
VIVEX Biologics, Inc.
- Location
- Shreveport, LA + 18 other US sites
- Eligibility basics
- Ages 22–85
- RecruitingPhase 3
Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease
CGBio Inc.
- Location
- Shreveport, LA + 7 other US sites
- Eligibility basics
- Ages 21–80
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Shreveport, LA + 54 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
GlaxoSmithKline
- Location
- Shreveport, LA + 13 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Shreveport, LA + 37 other US sites
- Eligibility basics
- Ages 40–75
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Shreveport, LA + 131 other US sites
- Eligibility basics
- Ages 65+
- Recruiting
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Urotronic Inc.
- Location
- Shreveport, LA + 6 other US sites
- Eligibility basics
- Ages 50+ · Men only
- Recruiting
PerQdisc Traditional Feasibility Trial.
Spinal Stabilization Technologies
- Location
- Shreveport, LA + 4 other US sites
- Eligibility basics
- Ages 22–70
- RecruitingPhase 2
A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)
Tetraphase Pharmaceuticals, Inc
- Location
- Shreveport, LA + 4 other US sites
- Eligibility basics
- Ages 8–17
- RecruitingPhase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mirador Therapeutics, Inc.
- Location
- Shreveport, LA + 42 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
Pfizer
- Location
- Shreveport, LA + 4 other US sites
- Eligibility basics
- Ages 0 mo–17
- RecruitingHealthy volunteers
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
St. Jude Children's Research Hospital
- Location
- Shreveport, LA + 12 other US sites
- Eligibility basics
- Any age listed